Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor

BACKGROUND: Adoptive transfer of autologous T-lymphocytes transduced with a high affinity NY-ESO-1-reactive T-cell receptor (NY-ESO-1(c259) T-cells) has emerged as a promising therapeutic strategy for patients with refractory synovial sarcoma. Secondary autoimmune T-cell mediated toxicities can occu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Immunother Cancer
Päätekijät: Joseph, Jocelyn, Nathenson, Michael J., Trinh, Van Anh, Malik, Karan, Nowell, Erica, Carter, Kristen, Weathers, Shiao-Pei, Demetri, George D., Araujo, Dejka, Conley, Anthony P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2019
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6842215/
https://ncbi.nlm.nih.gov/pubmed/31703609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0759-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia